Bessemer Group Inc Biolife Solutions Inc Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Bessemer Group Inc holds 50 shares of BLFS stock, worth $1,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$1,358% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding BLFS
# of Institutions
199Shares Held
45MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$236 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$149 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$87 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$77.4 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$42.9 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.16B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...